Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | PPFIA4 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | DUSP26 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | NOL4 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-07 |
mRNA | ZNF610 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | GPR137C | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | PHACTR1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
mRNA | SLC35E2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |